Ketamine Hydrochloride
Ketamine Hydrochloride is a pharmaceutical drug with 82 clinical trials. Currently 23 active trials ongoing. Historical success rate of 88.2%.
Success Metrics
Based on 30 completed trials
Phase Distribution
Phase Distribution
13
Early Stage
22
Mid Stage
31
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
76.9%
30 of 39 finished
23.1%
9 ended early
23
trials recruiting
82
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)
HNC: Human Neural Circuits Electrophysiology During Cognition
Ketamine for Methamphetamine Use Disorder
Neurobiology of Suicide
Ketamine Treatment of Youth Suicide Attempters
Clinical Trials (82)
Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)
HNC: Human Neural Circuits Electrophysiology During Cognition
Ketamine for Methamphetamine Use Disorder
Neurobiology of Suicide
Ketamine Treatment of Youth Suicide Attempters
Imaging Depression in Parkinson's Disease
Prehospital Analgesia INtervention Trial (PAIN)
Ketamine for Treatment-Resistant Bipolar Disorder
Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression
Psychotherapy for Ketamine's Enhanced Durability in Chronic Neuropathic Pain: A Randomized Controlled Pilot Trial
Glutamatergic Mechanisms of Psychosis and Target Engagement (SA1)
Morphine or Ketamine for Analgesia
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
Ketamine in Severe Traumatic Brain Injury
Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression
i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial
Ketamine Versus Midazolam for Recurrence of Suicidality in Adolescents
Oral Ketamine for Treatment of Vaso-Occlusive Pain
The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Ketamine Sedation in the ICU (KANINE) RCT
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 82